
CZC-25146 hydrochloride
CAS No. 1330003-04-7
CZC-25146 hydrochloride ( —— )
产品货号. M19921 CAS No. 1330003-04-7
CZC-25146 是一种选择性 LRRK2 抑制剂,对野生型 LRRK2 和 G2019S LRRK2 的 IC50 分别为 4.76 nM/6.87 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥907 | 有现货 |
![]() ![]() |
10MG | ¥1604 | 有现货 |
![]() ![]() |
25MG | ¥2665 | 有现货 |
![]() ![]() |
50MG | ¥3985 | 有现货 |
![]() ![]() |
100MG | ¥5808 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称CZC-25146 hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CZC-25146 是一种选择性 LRRK2 抑制剂,对野生型 LRRK2 和 G2019S LRRK2 的 IC50 分别为 4.76 nM/6.87 nM。
-
产品描述CZC-25146 is a selective LRRK2 inhibitor with IC50 of 4.76 nM/6.87 nM for wild type LRRK2 and G2019S LRRK2 respectively.
-
体外实验CZC-25146 (0.01-5 μM; 7 days) does not cause cytotoxicity in human cortical neurons, nor blocking neuronal development.CZC-25146 (0.01-5 μM; 2 days) potently attenuates G2019S LRRK2-mediated toxicity in primary rodent neurons in a concentration-dependent manner with an EC50 of ~100 nM.CZC-25146 (0.06-1000 nM) rescues LRRK2 G2019S-induced neurite defects in primary human neurons in a dose-dependent manner.CZC-25146 (14.3 and 28.6 μM; 48 h) markedly reduces The mutant AAT encoded by the Z allele (ATZ) polymer load and restores AAT secretion in iPSC-Hepatocyte, without compromising cell viability. Cell Cytotoxicity Assay Cell Line:Human cortical neurons Concentration:0.01, 0.1, 1 and 5 μM Incubation Time:7 days Result:Did not cause cytotoxicity in human cortical neurons at concentrations below 5 μM over a seven-day treatment in culture, nor did it block neuronal development.
-
体内实验CZC-25146 (1 mg/kg for i.v.; 5 mg/kg for p.o.; single dosage) exhibits relatively good pharmacokinetic properties and an extensive distribution throughout animal body following intravenous injection into mice.CZC-25146 (250 mg/kg; p.o.; 14 days) reduces the ATZ polymer levels in over expressing human polymeric ATZ mice. Animal Model:Male CD-1 mice Dosage:1 mg/kg for i.v.; 5 mg/kg for p.o.Administration:i.v. and p.o.; single dosage Result:Pharmacokinetic Parameters of CZC-25146 in male CD-1 mice.Animal Model:Genetically modified male mice (6 weeks; over expressing human polymeric ATZ) Dosage:250 mg/kg Administration:p.o.; 14 days Result:Dramatically and reproducibly reduced the ATZ polymer levels with an overall reduction from 60% in the control group to 37%
-
同义词——
-
通路Autophagy
-
靶点LRRK2
-
受体LRRK2 (G2019S) LRRK2 (WT)
-
研究领域——
-
适应症——
化学信息
-
CAS Number1330003-04-7
-
分子量525
-
分子式C22H26ClFN6O4S
-
纯度>98% (HPLC)
-
溶解度DMSO: 15 mg/mL
-
SMILESCl.COc1cc(ccc1Nc1ncc(F)c(Nc2ccccc2NS(C)(=O)=O)n1)N1CCOCC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ramsden N et al. Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. ACS Chem Biol. 2011 Oct 21;6(10):1021-8.